Cargando…

Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma

Background: DLBCL represent a heterogeneous group of aggressive diseases. High grade B-cell lymphomas (HGBCL) were recently individualized from DLBCL as a discrete diagnostic entity due to their worse prognosis. Currently, although most patients are successfully treated with RCHOP regimens, 1/3 will...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petronilho, Sara, Sequeira, José Pedro, Paulino, Sofia, Lopes, Paula, Lisboa, Susana, Chacim, Sérgio, Lobo, João, Teixeira, Manuel, Jerónimo, Carmen, Henrique, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703891/ https://www.ncbi.nlm.nih.gov/pubmed/34945856 http://dx.doi.org/10.3390/jpm11121384

Ejemplares similares

Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP
por: Halahleh, Khalid, et al.
Publicado: (2023)

P1731: IBRUTINIB PLUS RCHOP VERSUS RCHOP ONLY, IN YOUNG PATIENTS WITH ACTIVATED B CELL-LIKE DIFFUSE LARGE B-CELL LYMPHOMA (ABC-DLBCL): A COST EFFECTIVENESS ANALYSIS
por: Rho, H., et al.
Publicado: (2022)

RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis
por: He, Yue, et al.
Publicado: (2021)

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP
por: Wang, Jing, et al.
Publicado: (2016)

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement
por: Kang, Byung Woog, et al.
Publicado: (2013)

Primary mediastinal large B-cell lymphoma: Clinical features, prognostic factors and survival with RCHOP in Arab patients in the PET scan era
por: Al Shemmari, Salem, et al.
Publicado: (2014)

The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients
por: ROŽMAN, SAMO, et al.
Publicado: (2016)

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
por: Witzig, T E, et al.
Publicado: (2017)

P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA
por: He, Q., et al.
Publicado: (2022)

Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma
por: Ma, Huixian, et al.
Publicado: (2021)

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis
por: Smonskey, Matthew, et al.
Publicado: (2016)

Two Cases of Diffuse Large B-Cell Lymphomas in the Cervical Lymph Nodes in Patients with Low-Grade Gastric Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
por: Jung, Ji Hoon, et al.
Publicado: (2013)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
por: Moore, Alison M., et al.
Publicado: (2018)

A rare case of follicular lymphoma transformed to a high‐grade B‐cell lymphoma in orbit
por: Vaddepally, Raju K., et al.
Publicado: (2019)

Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma
por: Abdulbaki, Rami, et al.
Publicado: (2021)

The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B‐cell lymphoma and enhances T‐cell recruitment
por: Yuan, Hepei, et al.
Publicado: (2021)

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
por: Akpa, Chidimma Agatha, et al.
Publicado: (2019)

EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
por: Ryan, Russell J. H., et al.
Publicado: (2011)

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?
por: Dubois, Sydney, et al.
Publicado: (2015)

Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma
por: Tagawa, Michihito, et al.
Publicado: (2018)

Primary cutaneous low-grade B-cell lymphoma treated with hydroxychloroquine
por: Lim, Megan, et al.
Publicado: (2020)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Persistent polyclonal B‐cell lymphocytosis: Illustration of the great mimicker of low‐grade B‐cell lymphoma
por: Nkosi, Dingani, et al.
Publicado: (2022)

Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
por: Abdur Raqib, Moosa, et al.
Publicado: (2023)

Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
por: Park, Sungryul, et al.
Publicado: (2020)

Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin
por: Morin, Ryan D., et al.
Publicado: (2010)

Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan
por: Izutsu, Koji, et al.
Publicado: (2021)

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
por: Bourne, Christopher M., et al.
Publicado: (2022)

Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance
por: Lee, Sung Hak, et al.
Publicado: (2014)

Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
por: Kesavan, Murali, et al.
Publicado: (2019)

Genetic modification of primary human B cells to model high-grade lymphoma
por: Caeser, Rebecca, et al.
Publicado: (2019)

Primary dural high grade B cell lymphoma mimicking subdural hematoma
por: Nakaya, Aya, et al.
Publicado: (2021)

Introduction to a Special Issue on Low-Grade B Cell Lymphoma in the Spleen
por: Nava, Victor E.
Publicado: (2021)

Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis
por: Karunakaran, Parathan, et al.
Publicado: (2022)

Quadri‐lineage disease involving nodal B‐cell marginal zone lymphoma, high‐grade B‐cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
por: Laribi, Kamel, et al.
Publicado: (2015)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

Large B-cell lymphomas
por: Vitolo, Umberto
Publicado: (2019)

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dtfh6nvkao43en4uno28a468ip